Vanguard Asset Management »

Castle Biosciences shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $433k 18k 24.55

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Rtw Investments
Principal Financial Group
Portolan Capital Management
Vanguard Capital Management
Summit Partners Public Asset Management
Dimensional Fund Advisors
Vanguard Portfolio Management
Allianz Asset Management
State Street Corporation
Geode Capital Management
AIGH Capital Management
Palisade Capital Management
Nuveen

View all funds holding Castle Biosciences